137 related articles for article (PubMed ID: 25802280)
1. Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.
Liu YN; Yin J; Barrett B; Sheppard-Tillman H; Li D; Casey OM; Fang L; Hynes PG; Ameri AH; Kelly K
Mol Cell Biol; 2015 Jun; 35(11):1940-51. PubMed ID: 25802280
[TBL] [Abstract][Full Text] [Related]
2. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.
Chattopadhyay I; Wang J; Qin M; Gao L; Holtz R; Vessella RL; Leach RW; Gelman IH
Oncotarget; 2017 Feb; 8(6):10324-10347. PubMed ID: 28055971
[TBL] [Abstract][Full Text] [Related]
3. PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
Zennami K; Choi SM; Liao R; Li Y; Dinalankara W; Marchionni L; Rafiqi FH; Kurozumi A; Hatano K; Lupold SE
Mol Cancer Res; 2019 Feb; 17(2):618-627. PubMed ID: 30518628
[TBL] [Abstract][Full Text] [Related]
4. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer.
Ylitalo EB; Thysell E; Landfors M; Brattsand M; Jernberg E; Crnalic S; Widmark A; Hultdin M; Bergh A; Degerman S; Wikström P
Clin Epigenetics; 2021 Jun; 13(1):133. PubMed ID: 34193246
[TBL] [Abstract][Full Text] [Related]
5. Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone.
Fradet A; Bouchet M; Delliaux C; Gervais M; Kan C; Benetollo C; Pantano F; Vargas G; Bouazza L; Croset M; Bala Y; Leroy X; Rosol TJ; Rieusset J; Bellahcène A; Castronovo V; Aubin JE; Clézardin P; Duterque-Coquillaud M; Bonnelye E
Oncotarget; 2016 Nov; 7(47):77071-77086. PubMed ID: 27776343
[TBL] [Abstract][Full Text] [Related]
6. IL-1β expression driven by androgen receptor absence or inactivation promotes prostate cancer bone metastasis.
DiNatale A; Worrede A; Iqbal W; Marchioli M; Toth A; Sjöström M; Zhu X; Corey E; Feng FY; Zhou W; Fatatis A
Cancer Res Commun; 2022 Dec; 2(12):1545-1557. PubMed ID: 36561929
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.
Thysell E; Köhn L; Semenas J; Järemo H; Freyhult E; Lundholm M; Thellenberg Karlsson C; Damber JE; Widmark A; Crnalic S; Josefsson A; Welén K; Nilsson RJA; Bergh A; Wikström P
Mol Oncol; 2022 Feb; 16(4):846-859. PubMed ID: 34889043
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis.
Moro L; Simoneschi D; Kurz E; Arbini AA; Jang S; Guaragnella N; Giannattasio S; Wang W; Chen YA; Pires G; Dang A; Hernandez E; Kapur P; Mishra A; Tsirigos A; Miller G; Hsieh JT; Pagano M
Nat Cell Biol; 2020 Sep; 22(9):1130-1142. PubMed ID: 32839549
[TBL] [Abstract][Full Text] [Related]
9. A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.
Arriaga JM; Panja S; Alshalalfa M; Zhao J; Zou M; Giacobbe A; Madubata CJ; Kim JY; Rodriguez A; Coleman I; Virk RK; Hibshoosh H; Ertunc O; Ozbek B; Fountain J; Jeffrey Karnes R; Luo J; Antonarakis ES; Nelson PS; Feng FY; Rubin MA; De Marzo AM; Rabadan R; Sims PA; Mitrofanova A; Abate-Shen C
Nat Cancer; 2020 Nov; 1(11):1082-1096. PubMed ID: 34085047
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone.
Owen KL; Gearing LJ; Zanker DJ; Brockwell NK; Khoo WH; Roden DL; Cmero M; Mangiola S; Hong MK; Spurling AJ; McDonald M; Chan CL; Pasam A; Lyons RJ; Duivenvoorden HM; Ryan A; Butler LM; Mariadason JM; Giang Phan T; Hayes VM; Sandhu S; Swarbrick A; Corcoran NM; Hertzog PJ; Croucher PI; Hovens C; Parker BS
EMBO Rep; 2020 Jun; 21(6):e50162. PubMed ID: 32314873
[TBL] [Abstract][Full Text] [Related]
11. Macrophages and bone metastasis.
Di Mitri D; Conforti F; Mantovani A
J Exp Med; 2023 Apr; 220(4):. PubMed ID: 36828392
[TBL] [Abstract][Full Text] [Related]
12. EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1.
Chang YS; Chen WY; Yin JJ; Sheppard-Tillman H; Huang J; Liu YN
Cancer Res; 2015 Aug; 75(15):3077-86. PubMed ID: 26071255
[TBL] [Abstract][Full Text] [Related]
13. Integrative clinical genomics of advanced prostate cancer.
Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
[TBL] [Abstract][Full Text] [Related]
14. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
15. The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone.
Fournier PG; Juárez P; Jiang G; Clines GA; Niewolna M; Kim HS; Walton HW; Peng XH; Liu Y; Mohammad KS; Wells CD; Chirgwin JM; Guise TA
Cancer Cell; 2015 Jun; 27(6):809-21. PubMed ID: 25982816
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor regulates SRC expression through microRNA-203.
Siu MK; Chen WY; Tsai HY; Yeh HL; Yin JJ; Liu SY; Liu YN
Oncotarget; 2016 May; 7(18):25726-41. PubMed ID: 27028864
[TBL] [Abstract][Full Text] [Related]
17. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Zhang K; Zhao H; Ji Z; Zhang C; Zhou P; Wang L; Chen Q; Wang J; Zhang P; Chen Z; Zhu HH; Gao WQ
Oncogene; 2016 Mar; 35(10):1271-82. PubMed ID: 26050620
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
Segal CV; Koufaris C; Powell C; Gooderham NJ
Toxicology; 2015 Jul; 333():45-52. PubMed ID: 25846647
[TBL] [Abstract][Full Text] [Related]
19. The evolutionary history of lethal metastatic prostate cancer.
Gundem G; Van Loo P; Kremeyer B; Alexandrov LB; Tubio JMC; Papaemmanuil E; Brewer DS; Kallio HML; Högnäs G; Annala M; Kivinummi K; Goody V; Latimer C; O'Meara S; Dawson KJ; Isaacs W; Emmert-Buck MR; Nykter M; Foster C; Kote-Jarai Z; Easton D; Whitaker HC; ; Neal DE; Cooper CS; Eeles RA; Visakorpi T; Campbell PJ; McDermott U; Wedge DC; Bova GS
Nature; 2015 Apr; 520(7547):353-357. PubMed ID: 25830880
[TBL] [Abstract][Full Text] [Related]
20. Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
Ergun S; Oztuzcu S
Tumour Biol; 2015 May; 36(5):3129-36. PubMed ID: 25809705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
